Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ERBB3 |
| Upstream (Parents) |
|---|
| (<<) CRKL → ERBB3 |
| (<<) CYR61 → ERBB3 |
| (<<) E2F1 → ERBB3 |
| (<<) GNG4 → ERBB3 |
| (<<) HOXA3 → ERBB3 |
| (<<) HPS6 → ERBB3 |
| (<<) IL1F9 → ERBB3 |
| (<<) KRT1 → ERBB3 |
| (<<) MAL → ERBB3 |
| (<<) NCOA3 → ERBB3 |
| (<<) NRAS → ERBB3 |
| (<<) POU3F3 → ERBB3 |
| (<<) PRKACA → ERBB3 |
| (<<) RNF5 → ERBB3 |
| (<<) RRP15 → ERBB3 |
| Downstream (Children) |
|---|
| ERBB3 → EPHB6 (>>) |
| ERBB3 → MYL6B (>>) |
| ERBB3 → PCSK1N (>>) |
| ERBB3 → SOS2 (>>) |
